ArticleFrontiers in oncology2023

Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System.

Maria Antonietta Barbieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.